Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 juin 2018 07h30 HE | Source: Eyenovia, Inc.

Eyenovia Receives Notices of Allowance from USPTO on Two Additional Patent Applications for Ophthalmic Drug Delivery

NEW YORK, June 05, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented...
09 mai 2018 06h30 HE | Source: Eyenovia, Inc.

Eyenovia Reports First Quarter 2018 Financial Results and Completion of EYN PG21 Study

NEW YORK, May 09, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print...
19 avr. 2018 08h30 HE | Source: Eyenovia, Inc.

Eyenovia Announces Conference Call and Webcast for First Quarter 2018 Financial Results

NEW YORK, April 19, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented...
02 avr. 2018 06h30 HE | Source: Eyenovia, Inc.

Eyenovia Announces Fourth Quarter and Full Year 2017 Financial Results

NEW YORK, April 02, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented...
26 mars 2018 16h05 HE | Source: Eyenovia, Inc.

Eyenovia Appoints Three Industry Veterans to Board of Directors

NEW YORK, March 26, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented...
19 mars 2018 08h30 HE | Source: Eyenovia, Inc.

Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full Year 2017 Financial Results

NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- Eyenovia Inc. (“Eyenovia”) (NASDAQ:EYEN), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its...
27 févr. 2018 08h30 HE | Source: Eyenovia, Inc.

Eyenovia to Present at the 30th Annual ROTH Conference

NEW YORK, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Eyenovia Inc. (“Eyenovia”) (NASDAQ:EYEN), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its...
21 févr. 2018 08h30 HE | Source: Eyenovia, Inc.

Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee

NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Eyenovia Inc. (“Eyenovia”), (NASDAQ:EYEN), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its...
29 janv. 2018 16h05 HE | Source: Eyenovia, Inc.

Eyenovia Announces Closing of $27.3 Million Initial Public Offering

NEW YORK, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Eyenovia Inc. (“Eyenovia”), (NASDAQ:EYEN), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its...
25 janv. 2018 06h30 HE | Source: Eyenovia, Inc.

Eyenovia Announces Pricing of Initial Public Offering

NEW YORK, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Eyenovia Inc. (“Eyenovia”), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print...

Page précédente